Estimate Recalculated Nov 11, 2024 07:43AM EST
Matthew Emmens has an estimated net worth of $97.1 Million. This is based on reported shares across multiple companies, which include BRISTOL MYERS SQUIBB CO, VERTEX PHARMACEUTICALS INC / MA, and INCYTE CORP.
Matthew Emmens's CIK is 0001298332
2017 was Matthew Emmens's most active year for acquiring shares with 5 total transactions. Matthew Emmens's most active month to acquire stocks was the month of January. 2011 was Matthew Emmens's most active year for disposing of shares, totalling 4 transactions. Matthew Emmens's most active month to dispose stocks was the month of January. 2021 saw Matthew Emmens paying a total of $226,249.98 for 3,628.383 shares, this is the most they've acquired in one year. In 2011 Matthew Emmens cashed out on 65,735 shares for a total of $2,656,131.85, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!